Kineret 100 MG/0.67 ML syringe 0.67ML
Ended Awarded
- Contract number
- SPE2DX25F6MLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,162
Award facts
- Contract value 100% obligated
- $7,161.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This competitively awarded, firm fixed-price contract carries a ceiling value of $7,161.76 with an ultimate completion date of May 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement that extends through December 2026 and authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The contract contains no set-aside designation, indicating open competition for award. Kineret (anakinra) is a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other inflammatory conditions, representing the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers through its federal contract portfolio. The firm fixed-price structure and expedited delivery timeline of approximately three weeks demonstrate the efficiency mechanisms inherent in the DLA's prime vendor model for ensuring rapid availability of critical medical supplies to military customers.
Quick answers
Who was awarded contract SPE2DX25F6MLR?
SPE2DX25F6MLR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on April 23, 2025.
How much is contract SPE2DX25F6MLR worth?
The government has obligated $7,162 on SPE2DX25F6MLR.
Is contract SPE2DX25F6MLR an order under another contract?
Yes. SPE2DX25F6MLR is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6MLR competed?
The extent of competition for SPE2DX25F6MLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award